Contenu

21 janv.

Vous êtes ici : Accueil UMR 1027 > Les équipes de recherche > Equipe 4

Sélection de publications

Génomique, biothérapies et santé publique : approche interdisciplinaire


Bravo E, Calzolari A, De Castro P, Mabile L, Napolitani F, Rossi AM, Cambon-Thomsen A, Developing a guideline for a standardized citation of bioresources injournal articles (CoBRA). BMC Medicine.  2015. 13:33. doi: 10.1186/s12916-015-0266-y. abstract

Mahalatchimy A, Rial-Sebbag E, Duguet AM, Taboulet F, Cambon-Thomsen A.  The impact of European embryonic stem cell patent decisions on research strategies. Nat Biotech, 2015. 33: 41-43 accès

Mahalatchimy A, Rial-Sebbag E, Duguet AM, Cambon-Thomsen A, Taboulet F. Exclusion of patentability of Embryonic stem cells in Europe:another restriction by the European Patent Office. European Intellectual Property Review. 2015. 37(1): 5- 28. accès

Fransson MN, Rial-Sebbag E, Brochhausen M, Litton JE. Toward a common language for biobanking. Eur J Hum Genet. 2015. 23(1):22-8. doi: 10.1038/ejhg.2014.45. Epub2014 Apr 9. abstract

Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Duijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W. Beyond Public Genomics: proposalsfrom an International Working Group. Eur J Public Health. 2014. 24(6):876-8. accès

Cambon-Thomsen A.
[Actors and tools of predictive genetics: ethics at the heart of governance]. J Int Bioethique. 2014. 25(2):159-68. French abstract

Scelo G, Riazalhosseini Y, Greger L, Letourneau L, Gonzàlez-PortaM, Wozniak M B, Bourgey M, Harnden P, Egevad L, Jackson S M, KarimzadehM, Arseneault M, Lepage P, How-Kit A, Daunay A, Renault V, Blanché H,Tubacher E, Sehmoun J, Viksna J, Celms E, Opmanis M, Zarins A, Vasudev NS, Seywright M, Abedi-Ardekani B, Carreira C, Selby P J, Cartledge J J,Byrnes G, Zavadil J, Su J, Holcatova I, Brisuda A, Zaridze D, Moukeria A,Foretova L, Navratilova M, Mates D, Jinga V, Artemov A, Nedoluzhko A,Mazur A, Rastorguev S, Boulygina E, Heath S, Gut M, Bihoreau M T, LechnerD, Foglio M, Gut I G, Skryabin K, Prokhortchouk E, Cambon-Thomsen A, Rung J, Bourque G, Brennan P, Tost J, Banks R E, Brazma A, GLathrop M. Variation in genomic landscape of clear cell renal cellcarcinoma across Europe. Nat Commun. 2014. 29;5:5135 abstract

Rial-Sebbag E, Blasimme A. The European Court of Human Rights' ruling on unproven stem cell therapies: a missed opportunity?   Stem Cells Dev. 2014. suppl 1:39-43. doi:10.1089/scd.2014.0361. abstract

Rial-Sebbag E. [Personalized medicine, privatized medicine? legal and public health stakes]. Med Sci (Paris).2014. Spec n°2:36-40. doi:10.1051/medsci/201430s208.  French. abstract

Chabannon C, Sabatier F, Rial-Sebbag E, Calmels B, Veran J, Magalon G, Lemarie C, Mahalatchimy A. [Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products]. Med Sci (Paris). 2014. 30(5):576-83. doi: 10.1051/medsci/20143005022. French. abstract

Blasimme A, Rial-Sebbag E. Regulation of cell-based therapies in Europe: current challenges and emerging issues. Stem Cells Dev. 2013. 22 Suppl 1:14-9. doi:10.1089/scd.2013.0352. abstract

Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine. 2014. 81(3):228-34. doi: 10.1016/j.jbspin.2013.10.002. abstract

Meslin EM, Blasimme A, Cambon-Thomsen A. Mapping the translational science policy 'valley of death. Clin Transl Med. 2013.2(1):14. doi: 10.1186/2001-1326-2-14. abstract

Anastasova V, Mahalatchimy A, Rial-Sebbag E, Antó Boque JM, Keil T, Sunyer J, Bousquet J, Cambon-Thomsen A. Communication of results and disclosure of incidental findings in longitudinal paediatric research. Pediatr Allergy Immunol 2013.24(4): 389-94. abstract

Ducournau P, Gourraud PA, Rial-Sebbag E, Cambon-Thomsen A, Bulle A. Direct-to-consumer health genetic testing services: What commercial strategies for which socio-ethical issues ? Health Sociology Review. 2013.22(1):75-87. abstract

Mabile L, Dalgleish R, Thorisson GA, Deschênes M, Hewitt R, Carpenter J, Bravo E, Filocamo M, Gourraud PA, Harris JR, Hofman P, Kauffmann F, Muñoz-Fernàndez MA, Pasterk M, Cambon-Thomsen A. Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience. 2013.2(1):7. doi: 10.1186/2047-217X-2-7. abstract

Howard HC, Swinnen E, Douw K, Vondeling H, Cassiman JJ, Cambon-Thomsen A, Borry P. The ethical introduction of genome-based information and technologies into public health. Public Health Genomics. 2013.16(3):100-9.  doi: 10.1159/000346474. abstract


Publications antérieures
Lire

Date de mise à jour 6 mai 2015


UMR 1027 - Epidémiologie et analyses en santé publique : Risques, maladies chroniques et handicaps - Faculté de médecine 37 allées J. Guesde 31000 Toulouse
Inserm Université de Toulouse Université Toulouse III - Paul Sabatier